Colorblindness linked to delayed bladder cancer detection and higher mortality
View as a Web Page
News Medical
 
  Ophthalmology & Optometry Ophthalmology & Optometry logo  
  The latest ophthalmology / optometry news from News Medical  
 Silent thief of sight: Rutgers Health experts highlight glaucoma risks, early detectionSilent thief of sight: Rutgers Health experts highlight glaucoma risks, early detection
 
January is Glaucoma Awareness Month, prompting Rutgers Health experts to underscore the importance of early detection and public awareness.
 
 
 Colorblindness linked to delayed bladder cancer detection and higher mortalityColorblindness linked to delayed bladder cancer detection and higher mortality
 
Recognizing the sight of blood in urine, the most common first sign of bladder cancer, is often the impetus that leads people to a diagnosis.
 
   UK glaucoma cases expected to rise sharply due to aging populationUK glaucoma cases expected to rise sharply due to aging population
 
The number of people over 40 in the UK living with glaucoma-the leading cause of irreversible blindness worldwide-is already higher than expected and is projected to surge to more than 1.6 million by 2060, finds research published online in the British Journal of Ophthalmology.
 
 Ultra-thin nanotechnology enables safe wireless stimulation for retinal degeneration
 
An international research team led by Prof. Dr. Sedat Nizamoğlu from the Department of Electrical and Electronics Engineering at Koç University has developed a next-generation, safe, and wireless stimulation technology for retinal degenerative diseases that cause vision loss.
 
 
 Petrolatum ointments cause microshunt swelling, rupture in glaucoma patients
 
Widely-used eye ointments can cause glaucoma implants to swell and potentially rupture, according to new research from Nagoya University in Japan.
 
 
 UT Southwestern performs first regional whole-liver chemotherapy for rare eye cancer
 
A team at UT Southwestern Medical Center this week became the first in Texas and neighboring states to successfully perform a novel procedure to deliver whole-liver chemotherapy to treat metastatic uveal melanoma, a rare and deadly eye cancer.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026